Paritaprevir/ritonavir, Ombitasvir, Dasabuvir
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Paritaprevir/ritonavir, Ombitasvir, Dasabuvir, covering 2019-03-14 to 2019-06-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection [Phase 4]